Biologic therapies for chronic plaque psoriasis and cardiovascular events

JAMA

Volumn 306, Issue 19, 2011, Pages 2095-

  Tzellos, Thrasivoulos ^a   Kyrgidis, Athanassios ^a   Toulis, Konstantinos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ROSIGLITAZONE; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 23 ANTIBODY; PLACEBO; ROFECOXIB;

BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASE; CHRONIC PLAQUE PSORIASIS; EFFECT SIZE; HUMAN; LETTER; MANTEL HAENSZEL TEST; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PSORIASIS VULGARIS; RISK FACTOR; CHEMICALLY INDUCED DISORDER; HEART INFARCTION; NOTE; PSORIASIS; STROKE; CARDIOVASCULAR RISK; DRUG SAFETY; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; THROMBOSIS;

ANTIBODIES, MONOCLONAL; CARDIOVASCULAR DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MYOCARDIAL INFARCTION; PSORIASIS; STROKE;

EID: 81255189639     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1660     Document Type: Letter

References (5)

1. Ryan C, Leonardi CL, Krueger JG, et al. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: ameta-analysis of randomized controlled trials. JAMA. 2011;306(8):864-871.
2. Hernandez AV, Walker E, Ioannidis JP, Kattan MW. Challenges in metaanalysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. Am Heart J. 2008;156(1):23-30.
3. Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53-77. (Pubitemid 46099417)
4. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008- 2012. (Pubitemid 30214957)
5. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296(13):1633-1644. (Pubitemid 44511610)